# AstraZeneca (AZN) total debt: $29.15B in 2025

URL: https://funkfolio.com/stock/AZN/total-debt

> AstraZeneca (AZN) total debt was $29.15B at the end of fiscal 2025, down 3.2% from fiscal 2024. Year-by-year chart and table.

---

## AstraZeneca (AZN) total debt

**Total debt · fiscal 2025:** $29.15B at Dec 31, 2025

AstraZeneca (AZN) carried total debt of $29.15B at the end of fiscal 2025 (December 31, 2025). That is 3.2% lower than the $30.11B of fiscal 2024. Figures as of 18 Nov 2026, 11:37 UTC, from Yahoo Finance.

### Key facts

- **Total debt, fiscal 2025:** $29.15B
- **Change on fiscal 2024:** −3.2%
- **Highest on record:** $30.11B fiscal 2024
- **Lowest on record:** $28.41B fiscal 2023
- **Fiscal years on record:** 4 2022–2025

Figures as of 18 Nov 2026, 11:37 UTC. Statements from Yahoo Finance. Amounts are in USD. Figures, not advice.

### AstraZeneca total debt, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $30.11B in fiscal 2024 and the lowest $28.41B in fiscal 2023.

Total debt was 0.6× shareholders' equity at the end of fiscal 2025.

### Total debt by fiscal year

### AstraZeneca total debt, year by year

AstraZeneca (AZN) total debt by fiscal year

| Fiscal year | Total debt | Change | Year ended | Debt ÷ equity |
| --- | --- | --- | --- | --- |
| 2025 | $29.15B | 3.2% down | Dec 31, 2025 | 0.6× |
| 2024 | $30.11B | 6.0% up | Dec 31, 2024 | 0.7× |
| 2023 | $28.41B | 2.5% down | Dec 31, 2023 | 0.7× |
| 2022 | $29.14B | — | Dec 31, 2022 | 0.8× |

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

### How it is calculated

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

### How to read it

Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.

### Total debt at health care companies of similar size

Total debt of AstraZeneca and comparable companies

| Company | Total debt | Fiscal year |
| --- | --- | --- |
| [Merck & Co MRK](https://funkfolio.com/stock/MRK/total-debt) | $49.34B | 2025 |
| [UnitedHealth Group UNH](https://funkfolio.com/stock/UNH/total-debt) | $78.39B | 2025 |
| [Novartis NVS](https://funkfolio.com/stock/NVS/total-debt) | $35.38B | 2025 |
| AstraZeneca AZN | $29.15B | 2025 |
| [Thermo Fisher Scientific TMO](https://funkfolio.com/stock/TMO/total-debt) | $39.39B | 2025 |
| [Amgen AMGN](https://funkfolio.com/stock/AMGN/total-debt) | $54.60B | 2025 |

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

### AstraZeneca, figure by figure

- [AstraZeneca market cap](https://funkfolio.com/stock/AZN/market-cap)
- [AstraZeneca revenue](https://funkfolio.com/stock/AZN/revenue)
- [AstraZeneca earnings](https://funkfolio.com/stock/AZN/earnings)
- [AstraZeneca earnings per share (EPS)](https://funkfolio.com/stock/AZN/eps)
- [AstraZeneca P/E ratio](https://funkfolio.com/stock/AZN/pe-ratio)
- [AstraZeneca P/S ratio](https://funkfolio.com/stock/AZN/ps-ratio)
- [AstraZeneca P/B ratio](https://funkfolio.com/stock/AZN/pb-ratio)
- [AstraZeneca free cash flow](https://funkfolio.com/stock/AZN/free-cash-flow)
- [AstraZeneca operating margin](https://funkfolio.com/stock/AZN/operating-margin)
- [AstraZeneca dividend](https://funkfolio.com/stock/AZN/dividend)
- [AstraZeneca shares outstanding](https://funkfolio.com/stock/AZN/shares-outstanding)
- [AstraZeneca cash on hand](https://funkfolio.com/stock/AZN/cash)
- [AstraZeneca total assets](https://funkfolio.com/stock/AZN/total-assets)
- [AstraZeneca return on equity (ROE)](https://funkfolio.com/stock/AZN/roe)
- [AstraZeneca return on invested capital (ROIC)](https://funkfolio.com/stock/AZN/roic)

[AstraZeneca (AZN) overview: price, valuation and scorecard](https://funkfolio.com/stock/AZN) [All health care companies by market value](https://funkfolio.com/companies/sector/health-care)

### AstraZeneca total debt: questions and answers

**How much debt does AstraZeneca have?**

AstraZeneca (AZN) carried total debt of $29.15B at the end of fiscal 2025 (December 31, 2025). That is 3.2% lower than the $30.11B of fiscal 2024.

**What are the highest and lowest total debt figures on record for AstraZeneca?**

Across the 4 fiscal years on record (2022–2025), the highest was $30.11B in fiscal 2024 and the lowest $28.41B in fiscal 2023.

**How does AstraZeneca's debt compare with its equity?**

Total debt was 0.6× shareholders' equity at the end of fiscal 2025.

**How is AstraZeneca's total debt calculated?**

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative. For AstraZeneca it is on record here for 4 fiscal years, 2022 to 2025.

Fiscal years are named for the calendar year they end in.

### Learn: total debt

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- [Market cap vs enterprise value: what is the difference?](https://funkfolio.com/learn/markets/market-cap-vs-enterprise-value)

  Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- [Analyst price targets and ratings: what they mean](https://funkfolio.com/learn/stocks/analyst-price-targets)

  An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.

### Cite this page

Funkfolio, “AstraZeneca (AZN) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/AZN/total-debt

Underlying data: Yahoo Finance.
